arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

LENSAR, Inc.

LNSR
$5.51 ▼ -0.24 (-4.09%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
8 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
50
Health
Fair
Neutral
auto_awesome

Analytical Summary

LENSAR, Inc. shows mixed fundamentals. On the positive side, Return on Common Equity (%) remains strong. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $65.9M
Dividend Yield —
Revenue Growth 9.2% ↘
Op. Margin -42.1% ↘
ROIC 74.6% ↗
FCF / Share $-1.25 ↘
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$58.44M
↑ +9.2% —
Net Income Profit after all expenses
$-34.28M
↓ -9.2% —
Operating Margin Operating profit as % of sales
-42.1%
↓ -111.0% 6th
FCF / Share Free cash flow per share
$-1.25
↓ -490.9% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
6
Returns
100
Cash Quality ↓
37

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 31 quarters